Russian Pharmaceutical Industry Leader
About
Products
Press center
R&D
Career
Antifraud
Export
Contacts
News
Media publications
Information materials
Terms of use
Home
Press center
News
Аll
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
LLC Bratskhimsyntez
Export
Аll
2024
2023
2022
2021
2020
2019
2018
2017
03.11.2021
Pharmasyntez increases access to treatment of infectious diseases
Read more
29.10.2021
Pharmasyntez output increased 27%
Read more
18.10.2021
Pharmasyntez presented Saterex at the Rational Pharmacotherapy Congress
Read more
12.10.2021
Igor Moroz heads of the Irkutsk Pharmasyntez plant
Read more
05.10.2021
“Pharmaceutical industry innovations are first and for most about discovery of new molecules for the treatment of severe diseases” Natalya Malykh says
Read more
04.10.2021
“Russian Big Pharma must do a 180 degree turn in its way of thinking” Vikram Punia says
Read more
01.10.2021
Pharmasyntez presents a new line of female hormone drugs
Read more
22.09.2021
Remdeform is included into all COVID-19 treatment regimens
Read more
10.09.2021
Ruslan Bolotov, Mayor of Irkutsk, congratulated staff of the Pharmasyntez Group of Companies on the 24th anniversary of the enterprise
Read more
08.09.2021
Pharmasyntez turns 24!
Read more
31.08.2021
The launch of R&D centre at BratskChemSyntez LLC
Read more
25.08.2021
Pharmasyntez took part in the fifth innovation forum INNOWEEK 2.0
Read more
11.08.2021
BratskChemSyntez and Reshetnev Siberian State University developed a training program for synthesis operators
Read more
03.08.2021
Russian Healthcare Minister visits Pharmasyntez
Read more
02.08.2021
Russian Minister of Industry and Trade visits Pharmasyntez’ plant in Irkutsk
Read more
15.07.2021
Pharmasyntez is among the TOP-10 generic drug manufacturers
Read more
News:
← предыдущая
5
6
7
8
9
следующая →
About
History
Production
JSC Pharmasyntez
LLC EAST-PHARM
LLC PHARMASYNTEZ-TYUMEN
JSC PHARMASYNTEZ-NORD
LLC BratskChemSyntez
Quality management
Management
Social projects
Products
Anti-TB
Antibiotics
Cardiology
Corticoid hormones
COVID-19
Drugs for the treatment of diabetes mellitus
Endocrinology
Gynecology
HIV treatment
Infusion solutions
Injectable solutions
Local anesthetic agents
MRI agents
Multiple sclerosis
Neuroleptics
Neurology
Nonsteroidal anti-inflammatory drug
Nootropics
Oncology
Systemic mycoses
Therapeutic drugs
Transplantology
Treatment of hepatitis B
X-ray contrast agents
Сообщить о нежелательном явлении
Заполнить анкету по качеству
Press center
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
LLC Bratskhimsyntez
Export
R&D
R&D co-operation
Intellectual property
Publications
Career
Personnel policy
Training and career development
Antifraud
Export
Possibilities
News
Contacts
Head office
Moscow Office
East-Pharm
Pharmasyntez-Tyumen
Pharmasyntez-Nord
BratskChemSyntez